Literature DB >> 30209553

Renal cell carcinoma: standards and controversies.

Tobias Klatte1,2, Grant D Stewart3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30209553     DOI： 10.1007/s00345-018-2490-5

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  16 in total

1.  Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients.

Authors:  Y A M Kuijpers; R P Meijer; G N Jonges; J de Jong; J L H R Bosch; S Horenblas; A Bex
Journal:  World J Urol       Date:  2016-04-07       Impact factor: 4.226

2.  Cytoreductive Nephrectomy - Patient Selection Is Key.

Authors:  Robert J Motzer; Paul Russo
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

Review 3.  Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.

Authors:  Oscar Rodriguez Faba; Sabine D Brookman-May; Estefania Linares; Alberto Breda; Francesca Pisano; José Daniel Subiela; Francesco Sanguedolce; Maurizio Brausi; Joan Palou
Journal:  World J Urol       Date:  2017-07-12       Impact factor: 4.226

4.  Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Authors:  Vitaly Margulis; Shahrokh F Shariat; Yury Rapoport; Michael Rink; Daniel D Sjoberg; Nizar M Tannir; E Jason Abel; Stephen H Culp; Pheroze Tamboli; Christopher G Wood
Journal:  Eur Urol       Date:  2012-11-23       Impact factor: 20.096

Review 5.  Follow-up after curative treatment of localised renal cell carcinoma.

Authors:  Saeed Dabestani; Lorenzo Marconi; Teele Kuusk; Axel Bex
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226

6.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Authors:  Arnaud Méjean; Alain Ravaud; Simon Thezenas; Sandra Colas; Jean-Baptiste Beauval; Karim Bensalah; Lionnel Geoffrois; Antoine Thiery-Vuillemin; Luc Cormier; Hervé Lang; Laurent Guy; Gwenaelle Gravis; Frederic Rolland; Claude Linassier; Eric Lechevallier; Christian Beisland; Michael Aitchison; Stephane Oudard; Jean-Jacques Patard; Christine Theodore; Christine Chevreau; Brigitte Laguerre; Jacques Hubert; Marine Gross-Goupil; Jean-Christophe Bernhard; Laurence Albiges; Marc-Olivier Timsit; Thierry Lebret; Bernard Escudier
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

Review 7.  Prognostic factors and prognostic models for renal cell carcinoma: a literature review.

Authors:  Tobias Klatte; Sabrina H Rossi; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-30       Impact factor: 4.226

Review 8.  Genomics and clinical correlates of renal cell carcinoma.

Authors:  Thomas J Mitchell; Sabrina H Rossi; Tobias Klatte; Grant D Stewart
Journal:  World J Urol       Date:  2018-08-11       Impact factor: 4.226

Review 9.  Imaging for the diagnosis and response assessment of renal tumours.

Authors:  Sabrina H Rossi; Davide Prezzi; Christian Kelly-Morland; Vicky Goh
Journal:  World J Urol       Date:  2018-06-13       Impact factor: 4.226

Review 10.  Epidemiology and screening for renal cancer.

Authors:  Sabrina H Rossi; Tobias Klatte; Juliet Usher-Smith; Grant D Stewart
Journal:  World J Urol       Date:  2018-04-02       Impact factor: 4.226
View more
  9 in total

1.  Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma.

Authors:  Chenming Zhao; Yuri Tolkach; Doris Schmidt; Marieta Toma; Michael H Muders; Glen Kristiansen; Stefan C Müller; Jörg Ellinger
Journal:  World J Urol       Date:  2018-11-28       Impact factor: 4.226

2.  Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma.

Authors:  Jiachen Duan; Mengyuan Jin; Baoping Qiao
Journal:  Transl Oncol       Date:  2022-05-20       Impact factor: 4.803

3.  Up-Regulation of miR-26a-5p Inhibits E2F7 to Regulate the Progression of Renal Carcinoma Cells.

Authors:  Chuanyu Cheng; Liang Guo; Yaohui Ma; Zhe Wang; Xinpeng Fan; Zhongjie Shan
Journal:  Cancer Manag Res       Date:  2020-11-17       Impact factor: 3.989

4.  Identification and Verification of m7G Modification Patterns and Characterization of Tumor Microenvironment Infiltration via Multi-Omics Analysis in Clear Cell Renal Cell Carcinoma.

Authors:  Kai Dong; Di Gu; Jiazi Shi; Yewei Bao; Zhibin Fu; Yu Fang; Le Qu; Wentong Zhu; Aimin Jiang; Linhui Wang
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

5.  LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p.

Authors:  Zhuo Ye; Jiachen Duan; Lihui Wang; Yanli Ji; Baoping Qiao
Journal:  Cancer Cell Int       Date:  2019-11-21       Impact factor: 5.722

6.  The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.

Authors:  Siming Chen; Mengxue Yu; Lingao Ju; Gang Wang; Kaiyu Qian; Yu Xiao; Xinghuan Wang
Journal:  Cancer Cell Int       Date:  2021-02-18       Impact factor: 5.722

7.  Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.

Authors:  Jiachen Duan; Mengyuan Jin; Dongjing Yang; Jihua Shi; Jie Gao; Danfeng Guo; Hongwei Tang; Shuijun Zhang; Baoping Qiao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

8.  Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.

Authors:  Jinzhou Zheng; Wenhao Xu; Wangrui Liu; Haijia Tang; Jingen Lu; Kui Yu; Xiaoyun Song; Feng Li; Yu Wang; Rui Wang; Lili Chen; Hailiang Zhang; Yunhua Qiu; Gaomeng Wei; Xiqiu Zhou; Jianfeng Yang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  microRNA-505 negatively regulates HMGB1 to suppress cell proliferation in renal cell carcinoma.

Authors:  Bing Zhong; Zhiqiang Qin; Hui Zhou; Fengming Yang; Ke Wei; Xi Jiang; Ruipeng Jia
Journal:  J Cell Physiol       Date:  2019-01-15       Impact factor: 6.384
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.